We also observed that even though TP53 and KRAS were the most frequently mutated genes in cholangiocarcinoma (Fig. 6C), their mutation rates were only 26% and 20%, respectively, which were much lower than those in pancreatobiliary-type AAC and PAC. The gene discussed is KRAS; the disease is gonorrhea.